Effect of rosuvastatin on repeat heart failure hospitalizations: The CORONA trial (controlled rosuvastatin multinational trial in heart failure)

JACC: Heart Failure

Volumn 2, Issue 3, 2014, Pages 289-297

  Rogers, Jennifer K ^a   Jhund, Pardeep S ^b   Perez, Ana Cristina ^b   Böhm, Michael ^c   Cleland, John G ^d   Gullestad, Lars ^e   Kjekshus, John ^e   van Veldhuisen, Dirk J ^f   Wikstrand, John ^g   Wedel, Hans ^h   McMurray, John J V ^b   Pocock, Stuart J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c SAARLAND UNIVERSITY   (Germany)

^d UNIVERSITY OF HULL   (United Kingdom)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^g UNIVERSITY OF GOTHENBURG   (Sweden)

^h NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

Author keywords

Heart failure; Hospitalizations; Statins

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOW DENSITY LIPOPROTEIN; PLACEBO; ROSUVASTATIN; TRIACYLGLYCEROL; FLUOROBENZENE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIMIDINE DERIVATIVE; SULFONAMIDE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; FEMALE; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART EJECTION FRACTION; HEART FAILURE; HEART RATE; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HEART FAILURE; TRIACYLGLYCEROL BLOOD LEVEL; CHRONIC DISEASE; CLINICAL TRIAL; COMPLICATION; EPIDEMIOLOGY; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; MULTICENTER STUDY; MYOCARDIAL INFARCTION; RECURRENT DISEASE; STATISTICS AND NUMERICAL DATA;

AGED; CHRONIC DISEASE; EPIDEMIOLOGIC METHODS; FEMALE; FLUOROBENZENES; HEART FAILURE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PYRIMIDINES; RECURRENCE; SULFONAMIDES;

EID: 84901695453     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2013.12.007     Document Type: Article

References (18)

1. Kjekshus J., Dunselman P., Blideskog M., et al. A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristics. Eur J Heart Fail 2005, 7:1059-1069.
2. Kjekshus J., Apetrei E., Barrios V., et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007, 357:2248-2261.
3. Chun S., Tu J.V., Wijeysundera H.C., et al. Lifetime analysis of hospitalization and survival of patients newly admitted with heart failure. Circ Heart Fail 2012, 5:414-421.
4. Borer J.S., Böhm M., Ford I., et al. Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT study. Eur Heart J 2012, 33:2813-2820.
5. Rogers J.K., McMurray J.J.V., Pocock S.J., et al. Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalization. Circulation 2012, 126:2317-2323.
6. Rogers J.K., Pocock S.J., McMurray J.J.V., et al. Analysing recurrent hospitalisations in heart failure: a review of statistical methodology, with application to CHARM-Preserved. Eur J Heart Fail 2014, 16:33-40.
7. Ghosh D., Lin D.Y. Nonparametric analysis of recurrent events and death. Biometrics 2000, 56:554-562.
8. Glynn R.J., Buring J.E. Ways of measuring rates of recurrent events. BMJ 1996, 312:364-367.
9. Andersen P.K., Gill R.D. Cox's regression model for counting processes: a large sample study. Ann Stat 1982, 10:1100-1120.
10. Greenwood M., Yule G.U. An inquiry into the nature of frequency distributions representative of multiple happenings with particular reference to the occurrence of multiple attacks of disease or of repeated accidents. J R Stat Soc 1920, 83:255-279.
11. Lin D.Y., Wei L.J. The robust inference for the Cox proportional-hazards model. J Am Stat Assoc 1989, 84:1074-1078.
12. Liu L., Huang X. The use of Gaussian quadrature for estimation in frailty proportional-hazards models. Stat Med 2008, 27:2665-2683.
13. Gravning J., Askevold E.T., Nymo S.H., et al. Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial. Circ Heart Fail 2014, 7:96-103. CORONA Study Group.
14. Nymo S.H., Hulthe J., Ueland T., et al. Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA. Eur J Heart Fail 2014, 16:68-75.
15. Tavazzi L., Maggioni A.P., Marchioli R., et al. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1231-1239.
16. Yancy C.W., Jessup M., Bozkurt B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013, 62:1495-1539.
17. McMurray J.J., Adamopoulos S., Anker S.D., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur J Heart Fail 2012, 14:803-869.
18. Lambert D. Zero-inflated poisson regression, with an application to defects in manufacturing. Technometrics 1992, 34:1-14.